Register: The Future of mRNA Medicine: How Advanced Data Empowers Cures

Wayne Doyle began his career at Active Motif, where he led the bioinformatics team in developing analytical pipelines and supporting partners across research and drug development. In 2022, he joined Eclipsebio, where he now serves as Head of Scientific Strategy. At Eclipsebio, Wayne directs the company’s integrative partnership platforms that accelerate RNA therapeutic development, spanning end-to-end drug characterization and AI-powered optimization.

Fei started her industry career at New England Biolabs focusing on development of gene-editing enzymes. She was an early team member at Arrakis Therapeutics and contributed to building platforms for RNA-targeted drug discovery. She worked at one of the first circular RNA therapeutics companies before joining CSL Seqirus in 2023. Since then, she has been leading molecular science team to support sa-mRNA product development.

Lori is the head of insights at BioSpace. She analyzes and comments on industry trends for BioSpace and clients. She creates engaging content for clients to support their marketing objectives. She has been part of an award-winning marketing team and has won a Muse Creative award, a Vega award and several Adobe awards in collaborative team projects for her audio narration work. Her experience in the television/film and audio industries benefits both BioSpace and partners through her moderation and hosting of live and virtual events. While she has covered all elements of the drug development process, her primary focuses are women’s health issues, the economic climate, and the ever-evolving impact of technology – specifically artificial intelligence – on the pharmaceutical industry.